Status: Not yet recruiting
Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.
Participants needed: 100
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Galderma R&DUpdated: Jul 1, 2026Locations: 8
Eligibility criteria
Males or non-pregnant, non-breastfeeding females, 22 years of age or older. [+1]
Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA... [+5]